Tuesday November 24 2009 | Biotechnology feed | All feeds
|
|
PIramed Limited
Download detailed PDF Members: PIramed was founded by Professor Michael Waterfield FRS (Ludwig Institute for Cancer Research, London), Professor Peter Parker (Cancer Research UK) and Professor Paul Workman (Institute of Cancer Research, London). To date, the Company has received £10m in equity and convertible loans from JPMorgan Partners and Merlin Biosciences.Principal intellectual property licences are to PI 3-kinase p110a (from the Ludwig Institute of Cancer Research) and to small molecule inhibitors of PI 3-kinase superfamily members (from the Institutes and Astellas Pharma). The Company became operational in August 2003 and is based in state-of-the-art laboratory premises in Slough, Berkshire, UK.
This page has been viewed 850 times since April 2007, the link to the organisation's website has been followed 169 times Recent Search Terms used to find this page: PIRAMED LTD | PIramed Limited | PIramed | piramed 2009 | piramed slough | piramed | Piramed Intellectual Property | Piramed Limited | PIramed | piramed slough | . Search for more companies in Slough Search for more companies in Berkshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for PIramed Limited | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|